Somatic genomic testing involves either targeted panels that focus on specific genes known to drive GIST, such as KIT and PDGFRA, or broader panels that assess a wider array of genes for a more comprehensive analysis. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.